The importance of IL6 as a principal mediator for the tumour-promoting activity of senescent hMSCs was also evidenced by Di et al., who demonstrated that its secretion stimulated the proliferation and migration of breast cancer cells in vitro and, notably, did so in vivo in a co-transplant xenograft mouse model [92]. Here, IL6 is linked to breast cancer.